Guardant Historical Financial Ratios
| GH Stock | USD 40.35 2.09 4.92% |
Guardant Health is recently reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 88.45 will help investors to properly organize and evaluate Guardant Health financial condition quickly.
Guardant |
About Guardant Financial Ratios Analysis
Guardant HealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Guardant Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Guardant financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Guardant Health history.
Guardant Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Guardant Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Guardant Health sales, a figure that is much harder to manipulate than other Guardant Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Guardant Health dividend as a percentage of Guardant Health stock price. Guardant Health dividend yield is a measure of Guardant Health stock productivity, which can be interpreted as interest rate earned on an Guardant Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Guardant Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Cash Per Share is increasing as compared to previous years. The Guardant Health's current Days Payables Outstanding is estimated to increase to 58.41, while Price To Sales Ratio is projected to decrease to 4.82.
| 2024 | 2025 (projected) | Dividend Yield | 0.002485 | 0.00221 | Price To Sales Ratio | 5.07 | 4.82 |
Guardant Health fundamentals Correlations
Click cells to compare fundamentals
Guardant Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Guardant Health fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 43.83 | 27.12 | 6.18 | 5.37 | 5.07 | 4.82 | |
| Ptb Ratio | 9.68 | 15.71 | 46.18 | 19.09 | (26.85) | (25.51) | |
| Days Sales Outstanding | 67.85 | 95.39 | 78.97 | 57.46 | 54.45 | 88.45 | |
| Book Value Per Share | 13.9 | 6.37 | 0.59 | 1.42 | (1.14) | (1.08) | |
| Free Cash Flow Yield | (0.0126) | (0.028) | (0.14) | (0.11) | (0.0733) | (0.077) | |
| Operating Cash Flow Per Share | (1.07) | (2.06) | (3.03) | (2.9) | (1.95) | (2.05) | |
| Stock Based Compensation To Revenue | 0.0791 | 0.5 | 0.41 | 0.21 | 0.16 | 0.19 | |
| Capex To Depreciation | 2.83 | 1.56 | 3.37 | 2.15 | 0.83 | 0.79 | |
| Pb Ratio | 9.68 | 15.71 | 46.18 | 19.09 | (26.85) | (25.51) | |
| Ev To Sales | 43.88 | 29.44 | 8.91 | 5.76 | 6.17 | 5.86 | |
| Free Cash Flow Per Share | (1.62) | (2.8) | (3.79) | (3.08) | (2.24) | (2.35) | |
| Roic | (0.0894) | (0.12) | (0.2) | (0.38) | (0.35) | (0.36) | |
| Inventory Turnover | 4.07 | 4.01 | 3.03 | 3.67 | 4.08 | 4.96 | |
| Net Income Per Share | (2.53) | (3.8) | (6.41) | (4.28) | (3.56) | (3.73) | |
| Days Of Inventory On Hand | 89.6 | 91.09 | 120.48 | 99.59 | 89.53 | 68.94 | |
| Payables Turnover | 12.61 | 6.99 | 2.27 | 4.39 | 7.52 | 6.79 | |
| Sales General And Administrative To Revenue | 0.67 | 0.55 | 0.36 | 0.28 | 0.24 | 0.48 | |
| Research And Ddevelopement To Revenue | 0.52 | 0.7 | 0.83 | 0.65 | 0.47 | 0.46 | |
| Capex To Revenue | 0.19 | 0.2 | 0.17 | 0.0363 | 0.0475 | 0.0451 | |
| Cash Per Share | 18.41 | 9.21 | 9.9 | 10.44 | 6.84 | 7.01 | |
| Pocfratio | (120.91) | (48.48) | (8.98) | (9.32) | (15.63) | (16.42) | |
| Interest Coverage | (53.49) | (159.49) | (211.24) | (219.06) | (171.87) | (180.46) | |
| Capex To Operating Cash Flow | (0.45) | (0.52) | (0.36) | (0.25) | (0.063) | (0.15) | |
| Pfcf Ratio | (79.54) | (35.67) | (7.18) | (8.77) | (13.64) | (14.32) | |
| Days Payables Outstanding | 28.95 | 52.21 | 160.9 | 83.18 | 48.55 | 58.41 | |
| Income Quality | 0.42 | 0.54 | 0.47 | 0.68 | 0.55 | 0.72 | |
| Roe | (0.19) | (0.6) | (10.88) | (3.02) | 3.12 | 3.28 | |
| Ev To Operating Cash Flow | (121.06) | (52.64) | (12.95) | (10.0) | (19.01) | (19.96) | |
| Pe Ratio | (51.02) | (26.34) | (4.25) | (6.32) | (8.59) | (9.02) | |
| Return On Tangible Assets | (0.11) | (0.18) | (0.41) | (0.27) | (0.3) | (0.31) | |
| Ev To Free Cash Flow | (79.63) | (38.73) | (10.36) | (9.41) | (16.59) | (17.42) | |
| Earnings Yield | (0.009584) | (0.0196) | (0.038) | (0.24) | (0.16) | (0.12) | |
| Intangibles To Total Assets | 0.008579 | 0.007937 | 0.009327 | 0.006868 | 0.006765 | 0.0134 | |
| Net Debt To E B I T D A | (0.0661) | (2.42) | (2.0) | (0.51) | (2.08) | (1.97) | |
| Current Ratio | 28.27 | 5.72 | 6.17 | 6.54 | 4.68 | 4.44 | |
| Tangible Book Value Per Share | 13.7 | 6.19 | 0.44 | 1.31 | (1.22) | (1.16) | |
| Receivables Turnover | 5.38 | 3.83 | 4.62 | 6.35 | 6.7 | 4.0 | |
| Graham Number | 27.51 | 23.32 | 9.21 | 11.68 | 9.54 | 17.09 | |
| Shareholders Equity Per Share | 13.32 | 6.37 | 0.59 | 1.42 | (1.14) | (1.08) | |
| Debt To Equity | 0.65 | 2.11 | 22.75 | 8.53 | (9.57) | (9.09) |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.56) | Revenue Per Share | Quarterly Revenue Growth 0.302 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.